In this T1D population, sotagliflozin increased copeptin levels, FELi, and FEGlucose without altering renin, reflecting adaptive mechanisms that preserve sodium and fluid balance and protect against volume depletion. Sotagliflozin also decreased markers of kidney injury and increased haematocrit.
Nardone et al. (Tue,) studied this question.